VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Shanxi Xinghuacun Fen Wine Factory Co., Ltd. vs GSK plc
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Shanxi Xinghuacun Fen Wine Factory Co., Ltd.
600809 · Shanghai Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Shanxi Xinghuacun Fen Wine Factory Co., Ltd.'s moat claims, evidence, and risks.
View 600809 analysisGSK plc
GSK · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: GSK plc leads (62 / 100 vs 57 / 100 for Shanxi Xinghuacun Fen Wine Factory Co., Ltd.).
- Segment focus: Shanxi Xinghuacun Fen Wine Factory Co., Ltd. has 2 segments (73.7% in Mid-to-High Priced Liquor (>= RMB130/L)); GSK plc has 3 segments (37.6% in Specialty Medicines).
- Moat breadth: Shanxi Xinghuacun Fen Wine Factory Co., Ltd. has 5 moat types across 2 domains; GSK plc has 4 across 3.
Primary market context
Shanxi Xinghuacun Fen Wine Factory Co., Ltd.
Mid-to-High Priced Liquor (>= RMB130/L)
China premium baijiu (with focus on light-aroma baijiu) and mid-to-high priced spirits
China
Consumers and corporate/banquet demand via distributor/retail channels
Brand owner / distiller / wholesaler-distributor orchestrator
73.7%
GSK plc
Specialty Medicines
Branded specialty pharmaceuticals (HIV, oncology, immunology/respiratory)
Global
Hospitals, specialist physicians, payers
Innovator & branded manufacturer
37.6%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Shanxi Xinghuacun Fen Wine Factory Co., Ltd. strengths
GSK plc strengths
Segment mix
Shanxi Xinghuacun Fen Wine Factory Co., Ltd. segments
Full profile >Mid-to-High Priced Liquor (>= RMB130/L)
Oligopoly
Other Liquor (value-tier baijiu and other spirits)
Competitive
GSK plc segments
Full profile >Vaccines
Oligopoly
Specialty Medicines
Oligopoly
General Medicines
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.